Date |
Company |
Amount |
Funding type |
Investors |
Therapeutic area |
Type of Information |
2014-08-29 |
Orexo (Sweden) |
SEK 346.5 million (€37.7 million) |
private placement |
Swedish and international external institutional and strategic investors |
CNS diseases |
Private placement |
2014-08-29 |
Blueprint Genetics (Finland) |
$3.9 Million (€ 2.97 million) |
fundraising |
Inventure (Finland) Avohoidon Tutkimussäätiö (Finland) |
Technology - Services |
Fundraising |
2014-08-20 |
SimPrints (UK) |
£ 0.5 million (€0.62 million) |
grant |
Bill and Melinda Gates Foundation (USA) ARM Ltd (UK) |
Technology - Services |
Grant |
2014-08-19 |
Auris Medical (Switzerland) |
$60.7 million |
IPO |
|
Otorhinolaryngology |
IPO |
2014-08-13 |
Novosanis (Belgium) |
€ 0.25 million |
grant |
Flemish Agency for Innovation by Science and Technology (IWT) (Belgium) |
|
Grant |
2014-08-13 |
Ablynx (Belgium) |
€2.1 million |
grant |
Flemish Agency for Innovation by Science and Technology (IWT) (Belgium) |
Ophtalmological diseases |
Grant |
2014-08-08 |
Jazz Pharmaceuticals (Ireland) |
|
private placement |
|
Cancer - Oncology - CNS diseases |
Private placement |
2014-08-05 |
Phosphagenics (Australia) |
A$19.3 million (€13.3 million) |
private placement |
institutional and sophisticated investors in Europe, USA, Asia and Australia |
Technology - Services - CNS diseases |
Private placement |
2014-08-05 |
Diurnal (UK) |
up to £6 million (€ 7.54 million) |
fundraising |
IP Group (UK) |
Hormonal diseases - Endocrine diseases |
Fundraising |
2014-07-31 |
Macrocure (Israel) |
$ 54 million (€ 40.3 million) |
IPO |
|
Regenerative medicine |
IPO |
2014-07-31 |
Fate Therapeutics (USA - CA) |
up to $20 million |
long-term debt financing |
Silicon Valley Bank (USA - CA) |
Rare diseases |
Loan |
2014-07-30 |
VBL Therapeutics (Israel) |
|
IPO |
|
Cancer - Oncology - Immunological diseases - Inflammatory diseases |
IPO |
2014-07-30 |
Bio Blast Pharma (Israel) |
$ 35.2 million (€ 26.1 million) |
IPO |
|
Rare diseases - Genetic diseases |
IPO |
2014-07-30 |
Innocoll (Ireland) |
$ 51.5 million (€ 38.4 million) |
IPO |
Sofinnova Partners (France) |
Medical devices |
IPO |
2014-07-28 |
Ceva Santé Animale (France) |
undisclosed |
LMBO |
Mérieux Développement (France) Temasek (Singapore) CDH Investments (China) Euromezzanine (France) Sagard (France) |
Veterinary medicine |
Fundraising |
2014-07-24 |
Atox Bio (Israel) |
$23 Million |
Series E financing round |
SR One (UK) Lundbeckfond Ventures (Denamrk) OrbiMed Israel (Israel) |
Infectious diseases |
Financing round |
2014-07-24 |
Xention (UK) |
£1.4 million (€1.77 million) |
grant |
Technology Strategy Board (UK) |
Cardiovascular diseases |
Grant |
2014-07-24 |
University of Birmingham (UK) Biotie Therapies (Finland) |
€ 1 million |
grant |
National Institute for Health Research (NIHR) (UK) |
Inflammatory diseases |
Grant |
2014-07-24 |
4SC (Germany) Crelux (Germany) |
undisclosed |
grant |
m4 - Personalised Medicine and Targeted Therapies\' programme of the German Federal Ministry of Research and Education (BMBF) (Germany) |
Cancer - Oncology |
Grant |
2014-07-22 |
3P Biopharmaceuticals (Spain) |
€ 6 million |
capital increase |
Infarco (Spain) |
Technology - Services |
Capital increase |